Nihon Chouzai Co

Nihon Chouzai Co Quick Ratio

Delisted

The Quick Ratio (Acid Test) of Nihon Chouzai Co (3341.T) as of Oct 31, 2026 is 0.66. In the previous year, Quick Ratio (Acid Test) was 0.62 — a change of 5.45% (higher).

Quick Ratio

0.66

YoY

5.45%

Last updated:

Quick Ratio (Acid Test) of Nihon Chouzai Co is 2025 0.66 . Quick Ratio (Acid Test) of Nihon Chouzai Co was 2024 0.62 . It decreases by 5.45% higher compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Nihon Chouzai Co Stock analysis

What does Nihon Chouzai Co do? Nihon Chouzai Co Ltd is a Japanese pharmaceutical company that was founded in 1970. It specializes in the development and sale of pharmaceutical products and has built an impressive track record in recent decades. The business model of Nihon Chouzai is based on the manufacturing and sale of high-quality drugs for various diseases such as diabetes, hypertension, cardiovascular diseases, and cancer treatments. In addition, the company also offers a wide range of medical devices such as blood pressure monitors and insulin pens for diabetics. Another important division of Nihon Chouzai is the provision of pharmacy services to individual customers. The history of Nihon Chouzai began in the 1970s when the Japanese government launched a campaign to promote healthcare. The company recognized the importance of this campaign and started manufacturing quality drugs that were affordable for the general population. Since then, Nihon Chouzai has continuously invested in research and development to improve disease treatment. The company has also formed partnerships with other leading pharmaceutical companies worldwide to develop new medical technologies and treatment methods. In recent years, Nihon Chouzai has also conducted a number of acquisitions and mergers to expand its business. One of the most significant acquisitions was the acquisition of Daiichi Sankyo, a leading Japanese pharmaceutical company. In terms of products, Nihon Chouzai offers a wide range of drugs that cater to the needs of different patient groups. These include innovative cancer therapies, diabetes medications, lipid-lowering drugs, and blood pressure medications. Nihon Chouzai is also a leading provider of medical devices and consumables. The key products in this area are blood glucose monitors for diabetics, acupuncture needles for pain relief, and optical fiber endoscopic devices for gastroenterology. In addition to its consumer product offerings, Nihon Chouzai also provides specialized pharmacy services to individual customers. These services include setting up remote pharmacies for rural areas, conducting training for pharmacy technicians, and providing medical expertise to the public. Overall, Nihon Chouzai has established itself as a successful pharmaceutical and medical technology company that operates both in Japan and globally. The company relies on innovative research and development to meet the expectations of patients and doctors and improve healthcare. Nihon Chouzai Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Nihon Chouzai Co stock

Quick Ratio (Acid Test) of Nihon Chouzai Co is 0.66 in 2025.

Quick Ratio (Acid Test) of Nihon Chouzai Co changed from 0.62 to 0.66, representing a 5.45% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Quick Ratio (Acid Test) Nihon Chouzai Co since 2006 – with annual values, charts, and detailed analysis.

The Quick Ratio measures liquidity by comparing liquid assets to current liabilities, excluding inventory. It is a more conservative measure than the current ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Quick Ratio (Acid Test)'s Nihon Chouzai Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Nihon Chouzai Co

All Key Metrics — Nihon Chouzai Co